Genetic Literacy ProjectCRISPR crops—exempt from GMO regulations—reaching US market in record timeGenetic Literacy ProjectCRISPR–Cas9-edited plants can be cultivated and sold free from regulation, the US Department of Agriculture (USDA) is making incre… Continue reading
|
USRM Reaches Key Sales Milestone of Proprietary Adipocell™ Product
Markets Insider USRM is the premiere company in the United States that markets and manufactures an autologous adipose/stem cell separation kit. Autologous cells are not rejected by the body’s immune system and, as a result, may be more compatible and effective in … |
Cystic Fibrosis News Today |
Stemcell Develops New Mini-guts Line Grown from CF Patients to Test Therapies
Cystic Fibrosis News Today Using a cystic fibrosis patient’s tissue to grow mini-guts in a lab has become easier and is available to more scientists who want to use it both to study the disease and test patients’ response to therapies. Stemcell Technologies, a Canadian … |
Daily Beast |
This Doctor’s Revolutionary Stem Cell Treatments Could Eradicate HIV
Daily Beast For more than 30 frustrating years, doctors have struggled to find a cure for HIV. Now, with the help of stem cell research, they’re closer than ever before. “This approach has the potential to provide lifelong immunity to HIV,” Dr. Scott Kitchen, an … |
Seeking Alpha |
CRISPR Therapeutics: Buy The Secondary
Seeking Alpha A major milestone was achieved when they submitted their CTA for CTX001 in β-thalassemia. Preclinical data provides rationale for ushering the program forward and their CAR-T efforts should not be overlooked. Readers who have done their due diligence … Microsoft to use artificial intelligence to improve CRISPRDigital Journal After Reaching 52-Week High, Is CRISPR Therapeutics AG (CRSP)’s Near-Term Analysis Positive?Frisco Fastball Gene editing could be the future, but doctors think humans might be immune to itCBC.ca Dispatch Tribunal –StockNewsTimes –The Ledger Gazette –SEC.gov all 47 news articles » |
Duke Chronicle |
Promising stem cell therapy for scleroderma helps treat ‘haywire’ immune system, new study finds
Duke Chronicle For the approximately 300,000 Americans suffering from scleroderma, a recent Duke study may provide hope for a viable treatment. An autoimmune disease in which the body’s immune cells attack the skin—or even other organs, in some cases—scleroderma … |